Which of the following is a goal for the pharmacist when performing the patient interview?
Explanation & Rationale
The patient interview is a fundamental component of the clinical data collection process in pharmacy practice. Its primary purpose is to gather accurate information regarding a patient's medication history, health beliefs, and therapy goals. A successful interview requires the use of active listening and open-ended questions. This interaction serves as the foundation for identifying drug-related problems and developing a collaborative care plan that respects the patient's perspective. Rationale: A. To establish a trusting relationship is a primary goal of the interview, as it encourages honest communication and improves medication adherence. When a patient feels respected and heard, they are more likely to disclose sensitive information about side effects or missed doses. This therapeutic alliance is essential for the pharmacist to provide personalized and effective pharmaceutical care. B. Scolding a patient for non-adherence is counterproductive and damages the professional relationship. Such behavior creates a "blame culture" that discourages the patient from being honest about their challenges in the future. Instead, the pharmacist should use motivational interviewing techniques to identify barriers and support the patient in finding solutions to improve their health outcomes. C. Offering personal advice is inappropriate in a professional setting; the pharmacist must provide evidence-based clinical recommendations. Personal anecdotes do not carry the scientific weight required for safe medical guidance and may be biased. The pharmacist's role is to translate pharmacological data into actionable health information, not to share subjective opinions or personal lifestyle choices. D. Making a medical diagnosis is outside the scope of practice for a pharmacist; diagnosis is the legal responsibility of a physician or advanced practice provider. The pharmacist identifies medication-related problems and monitors drug therapy, but they do not define the underlying disease state. Misrepresenting a pharmacist's role as a diagnostic one can lead to legal and safety issues.